Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1007 | 2906 | 36.4 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
1906 | 2 | ALPHA 1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//ALPHA1 ANTITRYPSIN DEFICIENCY | 5908 |
1007 | 1 | ALPHA 1 ANTITRYPSIN DEFICIENCY//ALPHA 1 ANTITRYPSIN//ALPHA1 ANTITRYPSIN DEFICIENCY | 2906 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ALPHA 1 ANTITRYPSIN DEFICIENCY | authKW | 1308565 | 6% | 69% | 181 |
2 | ALPHA 1 ANTITRYPSIN | authKW | 1112481 | 8% | 43% | 247 |
3 | ALPHA1 ANTITRYPSIN DEFICIENCY | authKW | 770968 | 4% | 69% | 107 |
4 | ALPHA1 ANTITRYPSIN | authKW | 575194 | 5% | 41% | 133 |
5 | SERPIN | authKW | 520413 | 7% | 23% | 217 |
6 | ANTITRYPSIN | authKW | 238303 | 1% | 65% | 35 |
7 | AUGMENTATION THERAPY | authKW | 192051 | 1% | 52% | 35 |
8 | SERPINOPATHIES | authKW | 131318 | 1% | 83% | 15 |
9 | SERPINA1 | authKW | 123582 | 1% | 59% | 20 |
10 | PI SUBTYPES | authKW | 105932 | 0% | 92% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Respiratory System | 9422 | 15% | 0% | 442 |
2 | Biochemistry & Molecular Biology | 3982 | 33% | 0% | 959 |
3 | Genetics & Heredity | 1348 | 10% | 0% | 297 |
4 | Critical Care Medicine | 964 | 4% | 0% | 113 |
5 | Medical Laboratory Technology | 902 | 3% | 0% | 92 |
6 | Gastroenterology & Hepatology | 857 | 6% | 0% | 173 |
7 | Biophysics | 711 | 7% | 0% | 195 |
8 | Medicine, Research & Experimental | 626 | 7% | 0% | 192 |
9 | Pathology | 467 | 4% | 0% | 124 |
10 | Medicine, General & Internal | 400 | 7% | 0% | 206 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LUNG INVEST UNIT | 77796 | 1% | 37% | 20 |
2 | LUNG FUNCT SLEEP | 63551 | 0% | 55% | 11 |
3 | PROT STRAIN | 52529 | 0% | 100% | 5 |
4 | AD T PROJECT | 46794 | 0% | 64% | 7 |
5 | CAMBRIDGE MED | 45316 | 3% | 5% | 95 |
6 | EVALUAT RISKS HUMAN REPROD | 43773 | 0% | 83% | 5 |
7 | BIOCHIM BIOL MOL HMNO | 31518 | 0% | 100% | 3 |
8 | DIAG INHERITED ANTITRYPSIN DEFICIENCY ALPHA1 | 31518 | 0% | 100% | 3 |
9 | PEDIATUPMC NEWBORN MED PROGRAM | 31518 | 0% | 100% | 3 |
10 | SPANISH SOC PNEUMOL SEPAR | 31518 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 23166 | 1% | 6% | 37 |
2 | HUMAN HEREDITY | 11680 | 2% | 2% | 48 |
3 | RESPIRATORY MEDICINE | 3446 | 1% | 1% | 42 |
4 | HUMAN GENETICS | 2480 | 2% | 1% | 44 |
5 | ARCHIVOS DE BRONCONEUMOLOGIA | 2176 | 1% | 1% | 17 |
6 | CHEST | 2071 | 2% | 0% | 66 |
7 | BIOLOGICAL CHEMISTRY HOPPE-SEYLER | 1961 | 1% | 1% | 17 |
8 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1850 | 6% | 0% | 174 |
9 | MOLECULAR BIOLOGY & MEDICINE | 1815 | 0% | 3% | 6 |
10 | THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE | 1622 | 0% | 3% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALPHA 1 ANTITRYPSIN DEFICIENCY | 1308565 | 6% | 69% | 181 | Search ALPHA+1+ANTITRYPSIN+DEFICIENCY | Search ALPHA+1+ANTITRYPSIN+DEFICIENCY |
2 | ALPHA 1 ANTITRYPSIN | 1112481 | 8% | 43% | 247 | Search ALPHA+1+ANTITRYPSIN | Search ALPHA+1+ANTITRYPSIN |
3 | ALPHA1 ANTITRYPSIN DEFICIENCY | 770968 | 4% | 69% | 107 | Search ALPHA1+ANTITRYPSIN+DEFICIENCY | Search ALPHA1+ANTITRYPSIN+DEFICIENCY |
4 | ALPHA1 ANTITRYPSIN | 575194 | 5% | 41% | 133 | Search ALPHA1+ANTITRYPSIN | Search ALPHA1+ANTITRYPSIN |
5 | SERPIN | 520413 | 7% | 23% | 217 | Search SERPIN | Search SERPIN |
6 | ANTITRYPSIN | 238303 | 1% | 65% | 35 | Search ANTITRYPSIN | Search ANTITRYPSIN |
7 | AUGMENTATION THERAPY | 192051 | 1% | 52% | 35 | Search AUGMENTATION+THERAPY | Search AUGMENTATION+THERAPY |
8 | SERPINOPATHIES | 131318 | 1% | 83% | 15 | Search SERPINOPATHIES | Search SERPINOPATHIES |
9 | SERPINA1 | 123582 | 1% | 59% | 20 | Search SERPINA1 | Search SERPINA1 |
10 | PI SUBTYPES | 105932 | 0% | 92% | 11 | Search PI+SUBTYPES | Search PI+SUBTYPES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SANTANGELO, S , SCARLATA, S , POETA, ML , BIALAS, AJ , PAONE, G , INCALZI, RA , (2017) ALPHA-1 ANTITRYPSIN DEFICIENCY: CURRENT PERSPECTIVE FROM GENETICS TO DIAGNOSIS AND THERAPEUTIC APPROACHES.CURRENT MEDICINAL CHEMISTRY. VOL. 24. ISSUE 1. P. 65 -90 | 151 | 81% | 0 |
2 | STOLLER, JK , ABOUSSOUAN, LS , (2012) A REVIEW OF ALPHA(1)-ANTITRYPSIN DEFICIENCY.AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 185. ISSUE 3. P. 246 -259 | 114 | 80% | 83 |
3 | HENAO, MP , CRAIG, TJ , (2016) RECENT ADVANCES IN UNDERSTANDING AND TREATING COPD RELATED TO (1)-ANTITRYPSIN DEFICIENCY.EXPERT REVIEW OF RESPIRATORY MEDICINE. VOL. 10. ISSUE 12. P. 1281 -1294 | 118 | 87% | 0 |
4 | GOOPTU, B , LOMAS, DA , (2009) CONFORMATIONAL PATHOLOGY OF THE SERPINS: THEMES, VARIATIONS, AND THERAPEUTIC STRATEGIES.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 78. ISSUE . P. 147-176 | 111 | 78% | 99 |
5 | GREENE, CM , MARCINIAK, SJ , TECKMAN, J , FERRAROTTI, I , BRANTLY, ML , LOMAS, DA , STOLLER, JK , MCELVANEY, NG , (2016) ALPHA 1-ANTITRYPSIN DEFICIENCY.NATURE REVIEWS DISEASE PRIMERS. VOL. 2. ISSUE . P. - | 124 | 74% | 0 |
6 | SALAHUDDIN, P , (2010) GENETIC VARIANTS OF ALPHA(1)-ANTITRYPSIN.CURRENT PROTEIN & PEPTIDE SCIENCE. VOL. 11. ISSUE 2. P. 101-117 | 119 | 85% | 13 |
7 | DICKENS, JA , LOMAS, DA , (2011) WHY HAS IT BEEN SO DIFFICULT TO PROVE THE EFFICACY OF ALPHA-1-ANTITRYPSIN REPLACEMENT THERAPY? INSIGHTS FROM THE STUDY OF DISEASE PATHOGENESIS.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 5. ISSUE . P. 391 -405 | 104 | 92% | 18 |
8 | GOOPTU, B , DICKENS, JA , LOMAS, DA , (2014) THE MOLECULAR AND CELLULAR PATHOLOGY OF ALPHA(1)-ANTITRYPSIN DEFICIENCY.TRENDS IN MOLECULAR MEDICINE. VOL. 20. ISSUE 2. P. 116 -127 | 95 | 86% | 17 |
9 | EKEOWA, UI , GOOPTU, B , BELORGEY, D , HAGGLOF, P , KARLSSON-LI, S , MIRANDA, E , PEREZ, J , MACLEOD, I , KROGER, H , MARCINIAK, SJ , ET AL (2009) ALPHA(1)-ANTITRYPSIN DEFICIENCY, CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE SERPINOPATHIES.CLINICAL SCIENCE. VOL. 116. ISSUE 11-12. P. 837-850 | 121 | 78% | 30 |
10 | LOMAS, DA , HURST, JR , GOOPTU, B , (2016) UPDATE ON ALPHA-1 ANTITRYPSIN DEFICIENCY: NEW THERAPIES.JOURNAL OF HEPATOLOGY. VOL. 65. ISSUE 2. P. 413 -424 | 81 | 91% | 1 |
Classes with closest relation at Level 1 |